Heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia: The degree of thrombocytopenia caused by heparin has no clear relationship with the dose of heparin, the route of injection, and the history of previous heparin exposure, but is related to the source of the heparin preparation.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
All populations Heparin users -
Related symptoms:
Thrombocytopenia Intravascular coagulation Microthrombosis Thrombocytopenia -
Concurrent disease:
Related Drugs
Sodium deoxyribonucleotide tablets
Indication: Used as an auxiliary treatment for acute and chronic hepatitis, leukopenia, thrombocytopenia and aplastic anemia.
ANGIOMAX- bivalirudin_injection
Indication: Angiomax is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Angiomax is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS).
Manufacturer:
Sandoz Inc